Patent Assertion and “Privateering”: When Do Antitrust Law Concerns Arise when the Patent Is the Product?
The recording of this Media Briefing program (held on May 21) can be viewed in its entirety online. Click HERE.
Program focus:As federal antitrust officials continue to study the impact patent licensing and assertion have on market competition, concerns have been raised over “operating” companies’ relationships with patent-assertion entities. Can such “privateering” run afoul of antitrust laws or should regulators view such activity as a legitimate business practice at a time when patents are increasing seen as commodities?
- Suzanne Munck, Chief Counsel for Intellectual Property & Deputy Director, Office of Policy Planning, Federal Trade Commission
- Thomas C. Ewing, Esq., Avancept LLC
- Jonathan S. Kanter, Cadwalader, Wickersham & Taft LLP